ArticleCancer medicine2023

Bifidobacterium breve predicts the efficacy of anti-PD-1 immunotherapy combined with chemotherapy in Chinese NSCLC patients.

Honghui Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.